75A50122D00003↗
Sanofi Vaccines US Inc. received this contract vehicle from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $0 obligated so far for health r&d services; health care services; applied research. It runs to 2027-02-21.
Key facts · data as of Oct 23, 2026
- Recipient
- Sanofi Vaccines US Inc.
- Awarding agency
- Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Obligated to date
- $0
- Potential value
- $5.87B
- Ends
- 2027-02-21
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75A50122D00003, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_IDV_75A50122D00003_7505
Sanofi Vaccines US Inc.: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys · The follow-on: recompete brief
STOCKPILES OF PRE-PANDEMIC INFLUENZA COUNTERMEASURES, DOMESTIC VACCINE MANUFACTURING CAPACITY, AND PROCURE VACCINE INTERVENTIONS, INCLUDING VACCINES AND THERAPEUTICS TO MITIGATE THE PUBLIC HEALTH IMPACT OF EMERGING DISEASE THREATS.
Up for re-bid: ends 2027-02-21. Recompete brief → · Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response ↗
What it is
- Product or service
- Health R&D Services; Health Care Services; Applied Research (PSC AN12)
- Industry
- Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Competition
- Full and open competition · 3 offers received
- Pricing
- Firm fixed price
- How it was bought
- Contract vehicle (IDV) itself
- Solicitation
- 75A50121R00013
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Orders under this vehicle
14 orders worth $74.98M (current value). The largest:
- 75A50125F61012 · $24.87M · ends 2028-09-04
- 75A50124F61010 · $14.35M · ends 2025-09-30
- 75A50124F61008 · $12.58M · ends 2027-05-21
- 75A50126F61014 · $6.02M · ends 2027-09-29
- 75A50123F61007 · $4.28M · ends 2025-12-31
- 75A50123F61005 · $3.58M · ends 2024-02-21
- 75A50122F61001 · $3.38M · ends 2023-02-21
- 75A50122F61003 · $2.06M · ends 2023-12-10
- 75A50124F61009 · $1.53M · ends 2027-05-21
- 75A50126F61013 · $697.4K · ends 2029-07-31
- 75A50124F61011 · $681.0K · ends 2024-12-15
- 75A50123F61006 · $454.7K · ends 2024-02-21
- 75A50122F61002 · $454.7K · ends 2023-02-21
- 75A50123F61004 · $38.4K · ends 2023-02-21
Every action
6 actions since 2023-06-27. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-11 | P00007 | Vendor ID or name changed | $0 | STOCKPILES OF PRE-PANDEMIC INFLUENZA COUNTERMEASURES, DOMESTIC VACCINE MANUFACTURING CAPACITY, AND PROCURE VACCINE INTERVENTIONS, INCLUDING VACCINES AND THERAPEUTICS TO MITIGATE THE PUBLIC HEALTH IMPACT OF EMERGING DISEASE THREATS. |
| 2025-11-19 | P00006 | Administrative change | $0 | STOCKPILES OF PRE-PANDEMIC INFLUENZA COUNTERMEASURES, DOMESTIC VACCINE MANUFACTURING CAPACITY, AND PROCURE VACCINE INTERVENTIONS, INCLUDING VACCINES AND THERAPEUTICS TO MITIGATE THE PUBLIC HEALTH IMPACT OF EMERGING DISEASE THREATS. |
| 2025-11-13 | P00005 | Option exercised | $0 | STOCKPILES OF PRE-PANDEMIC INFLUENZA COUNTERMEASURES, DOMESTIC VACCINE MANUFACTURING CAPACITY, AND PROCURE VACCINE INTERVENTIONS, INCLUDING VACCINES AND THERAPEUTICS TO MITIGATE THE PUBLIC HEALTH IMPACT OF EMERGING DISEASE THREATS. |
| 2025-06-24 | P00004 | Supplemental agreement (work within scope) | $0 | STOCKPILES OF PRE-PANDEMIC INFLUENZA COUNTERMEASURES, DOMESTIC VACCINE MANUFACTURING CAPACITY, AND PROCURE VACCINE INTERVENTIONS, INCLUDING VACCINES AND THERAPEUTICS TO MITIGATE THE PUBLIC HEALTH IMPACT OF EMERGING DISEASE THREATS. |
| 2024-12-11 | P00003 | Administrative change | $0 | STOCKPILES OF PRE-PANDEMIC INFLUENZA COUNTERMEASURES, DOMESTIC VACCINE MANUFACTURING CAPACITY, AND PROCURE VACCINE INTERVENTIONS, INCLUDING VACCINES AND THERAPEUTICS TO MITIGATE THE PUBLIC HEALTH IMPACT OF EMERGING DISEASE THREATS. |
| 2023-06-27 | P00002 | Administrative change | $0 | REVISE KEY PERSONNEL, UPDATE CONTRACTING OFFICER, UPDATE INVOICE SUBMISSION, AND INCORPORATE IPP CLAUSE. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗